Clinical trial
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
NCT00062023 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00062023 |
|---|---|
| Title | Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer |
| Official title | Phase II Study Of Colorectal ACF Screening, Regression And Prevention In High Risk Participants |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Other |
| Interventions | Acetylsalicylic acid (Aspirin), Sulindac, Ursodiol, Sulindac Placebo |
| Enrollment | 12 |
| Start date | Jun 1, 2003 |
| Primary completion | Apr 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Jun 6, 2003 |
| Last update posted | Jul 30, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: